EARNEST Partners’s Bristol-Myers Squibb BMY Stock Holding History

EARNEST Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-947	Closed	-$55K	–	394
2023 Q3	$55K	Hold	947	–	–	﹤0.01%	357
2023 Q2	$60.6K	Hold	947	–	–	﹤0.01%	337
2023 Q1	$65.6K	Hold	947	–	–	﹤0.01%	329
2022 Q4	$68.1K	Hold	947	–	–	﹤0.01%	328
2022 Q3	$67K	Hold	947	–	–	﹤0.01%	309
2022 Q2	$73K	Sell	947 -200	-17%	-$15.2K	﹤0.01%	305
2022 Q1	$84K	Hold	1,147	–	–	﹤0.01%	303
2021 Q4	$72K	Hold	1,147	–	–	﹤0.01%	317
2021 Q3	$68K	Hold	1,147	–	–	﹤0.01%	317
2021 Q2	$77K	Hold	1,147	–	–	﹤0.01%	309
2021 Q1	$72K	Hold	1,147	–	–	﹤0.01%	305
2020 Q4	$71K	Hold	1,147	–	–	﹤0.01%	296
2020 Q3	$69K	Hold	1,147	–	–	﹤0.01%	289
2020 Q2	$67K	Hold	1,147	–	–	﹤0.01%	283
2020 Q1	$64K	Hold	1,147	–	–	﹤0.01%	279
2019 Q4	$74K	Buy	1,147 +358	+45%	+$20.5K	﹤0.01%	285
2019 Q3	$40K	Hold	789	–	–	﹤0.01%	331
2019 Q2	$36K	Hold	789	–	–	﹤0.01%	350
2019 Q1	$38K	Hold	789	–	–	﹤0.01%	338
2018 Q4	$41K	Hold	789	–	–	﹤0.01%	321
2018 Q3	$49K	Hold	789	–	–	﹤0.01%	318
2018 Q2	$44K	Hold	789	–	–	﹤0.01%	330
2018 Q1	$50K	Hold	789	–	–	﹤0.01%	309
2017 Q4	$48K	Buy	+789	New	+$49.4K	﹤0.01%	301
2017 Q1	–	Sell	-789	Closed	-$46K	–	331
2016 Q4	$46K	Buy	+789	New	+$43.1K	﹤0.01%	288

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

EARNEST Partners's BMY Position: Q4 2023 in Review

EARNEST Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 947 shares — an estimated $55K sold.

EARNEST Partners first reported a position in BMY in Q4 2016 and held it in 25 quarters. The position peaked at $84K in Q1 2022. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

EARNEST Partners reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 947 Bristol-Myers Squibb shares in Q4 2023, an estimated $55K.
EARNEST Partners first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Bristol-Myers Squibb position peaked at $84K in Q1 2022.
2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.